Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Y Miyagawa
Phase I/Ii Clinical Trial to Assess Safety and Efficacy of Intratumoral and Subcutaneous Injection of HVJ-E in Castration-Resistant Prostate Cancer Patients
Cancer Gene Therapy
Cancer Research
Molecular Medicine
Molecular Biology
Related publications
Intratumoral and Subcutaneous Injection of HVJ‐E (GEN0101) in Metastatic Castration‐resistant Prostate Cancer
Cancer Science
Cancer Research
Medicine
Oncology
Abiraterone in Metastatic Castration-Resistant Prostate Cancer: Efficacy and Safety in Unselected Patients
Cancer Treatment and Research Communications
Cancer Research
Oncology
Phase II Trial of Cisplatin Plus Prednisone in Docetaxel-Refractory Castration-Resistant Prostate Cancer Patients
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
A Multicenter Phase I/Ii Study of Enzalutamide in Japanese Patients With Castration-Resistant Prostate Cancer
International Journal of Clinical Oncology
Medicine
Surgery
Oncology
Hematology
Phase I Trial With a Combination of Docetaxel and 153Sm-Lexidronam in Patients With Castration-Resistant Metastatic Prostate Cancer
Urologic Oncology: Seminars and Original Investigations
Oncology
Urology
Erratum To: Cilengitide (EMD 121974, NSC 707544) in Asymptomatic Metastatic Castration Resistant Prostate Cancer Patients: A Randomized Phase II Trial by the Prostate Cancer Clinical Trials Consortium
Investigational New Drugs
Oncology
Pharmacology
Phase 1 Trial of High-Dose Exogenous Testosterone in Patients With Castration-Resistant Metastatic Prostate Cancer
European Urology
Urology
Safety and Preliminary Efficacy Analysis of the mTOR Inhibitor Ridaforolimus in Patients With Taxane-Treated, Castration-Resistant Prostate Cancer
Clinical Genitourinary Cancer
Oncology
Urology
Phase I/Ii Clinical Trial of Anti-Ox40, Radiation and Cyclophosphamide in Patients With Prostate Cancer: Immunological Analysis
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology